Lyra Therapeutics
Robert Langer is currently serving on the respective boards of directors of Abpro Corporation, Frequency Therapeutics, Inc., Rubius Therapeutics, Inc., Moderna, Inc., and Puretech Health plc. He received his Bachelor’s Degree from Cornell University and his Sc.D. from the Massachusetts Institute of Technology, both in Chemical Engineering.
This person is not in the org chart
This person is not in any offices
Lyra Therapeutics
Creating precisely tuned medicines so patients can breathe freely, Lyra Therapeutics is pioneering a new therapeutic approach to treat debilitating ear, nose and throat diseases that impact the lives of millions of people.